focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGYG.L Regulatory News (GYG)

  • There is currently no data for GYG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

5 Oct 2021 12:28

RNS Number : 0858O
Singer Capital Markets Sec Ltd
05 October 2021
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GYG PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

GYG PLC

(d) Date dealing undertaken:

04 October 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.002P

 

 

Sale

 

10,000

 

65.9p

 

65.9p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

05 October 2021

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUVUARANURRAA
Date   Source Headline
20th Nov 200711:55 amRNSEPT Disclosure
20th Nov 200711:42 amRNSRule 8.3- (Gyrus Group PLC)
20th Nov 200711:42 amRNSRule 8.3- Gyrus Group PLC
20th Nov 200711:25 amBUSRule 8.3 - Gyrus Group Plc
20th Nov 200710:53 amRNSEPT Disclosure
19th Nov 20073:57 pmRNSHolding(s) in Company
19th Nov 20077:02 amRNSAcquisition by Olympus
16th Nov 20077:01 amRNSStatement re Patent Dispute
9th Nov 20075:47 pmRNSHolding(s) in Company
7th Nov 200712:51 pmRNSHolding(s) in Company
31st Oct 20072:07 pmRNSTotal Voting Rights
29th Oct 200711:00 amBUSGyrus ACMI Introduces the World's First Endoscope Protection System (EPS) Designed to Prevent Accidental Laser Damage
25th Oct 20074:24 pmBUSGyrus ACMI to Market Revolutionary ''Bagless'' OPTION-v(TM) Valved Urinary Catheters
4th Oct 20079:22 amRNSHolding(s) in Company
1st Oct 20075:56 pmRNSTotal Voting Rights
24th Sep 20075:03 pmRNSHolding(s) in Company
17th Sep 20072:13 pmRNSDirector/PDMR Shareholding
17th Sep 20077:01 amRNSInterim Results
3rd Sep 20078:33 amRNSTotal Voting Rights
17th Aug 20079:13 amRNSDirector/PDMR Shareholding
31st Jul 20075:45 pmRNSTotal Voting Rights
30th Jul 20074:58 pmRNSFurther re Additional Listing
27th Jul 20073:34 pmRNSAdditional Listing
17th Jul 20077:00 amRNSTrading Statement
8th Jun 20073:30 pmRNSDirector/PDMR Shareholding
8th Jun 20073:24 pmRNSDirector/PDMR Shareholding
8th Jun 20073:20 pmRNSBlocklisting Interim Review
6th Jun 20077:01 amRNSDirector/PDMR Shareholding
4th Jun 20075:21 pmRNSDirector/PDMR Shareholding
1st Jun 20077:01 amRNSAppointment of CEO
31st May 20072:11 pmRNSTotal Voting Rights
24th May 200710:12 amRNSHolding(s) in Company
11th May 20074:18 pmRNSDirector/PDMR Shareholding
2nd May 20072:41 pmRNSResult of AGM
2nd May 20072:33 pmRNSTotal Voting Rights
30th Apr 20074:49 pmRNSResult of AGM
23rd Apr 20073:14 pmRNSHolding(s) in Company
20th Apr 20074:07 pmRNSAnnual Information Update
5th Apr 20072:48 pmRNSAnnual Report and Accounts
30th Mar 20073:26 pmRNSTotal Voting Rights
27th Mar 20076:23 pmRNSDirector/PDMR Shareholding
27th Mar 20076:17 pmRNSDirector/PDMR Shareholding
27th Mar 20076:01 pmRNSHolding(s) in Company
26th Mar 200711:50 amRNSDirector/PDMR Shareholding
19th Mar 20072:37 pmRNSHolding(s) in Company
19th Mar 20072:30 pmRNSHolding(s) in Company
16th Mar 20077:01 amRNSFinal Results
13th Mar 20074:03 pmRNSHolding(s) in Company
13th Mar 20073:56 pmRNSHolding(s) in Company
28th Feb 200712:33 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.